Published Date: July 2024
Highly skilled and experienced scientists who serve as a strong support system for the business process of the biopharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant centre for biopharmaceutical research and development (R&D), especially for vaccine manufacturing. Also, government action towards innovative program boosting bio-pharmaceutical production in the country. India Biopharmaceutical Market Size was valued at US$ 2.1 billion in 2024 and is expected to grow at a CAGR of 24.8% to reach US$ 15.8 billion by 2034.
The report "India Biopharmaceutical Market Size, Share, By Type (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and, Others) and By Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others) - Trends, Analysis, and Forecasts till 2034"
Key Highlights:
- In February 2017, Cipla, Serum Institute launch Hepatitis B vaccine. Global CEO Umang Vohra said the agreement will enable Cipla to provide affordable vaccines for a chronic disease like Hepatitis B. Cipla's strong marketing network and reach will ensure maximum accessibility of the vaccines in India.
Key Market Insights from the report:
India Biopharmaceutical Market Size was valued at US$ 2.1 billion in 2024 and is expected to grow at a CAGR of 24.8% to reach US$ 15.8 billion by 2034. The market report has been segmented based on type, and application.
- By type, the monoclonal antibody segment dominated the global biopharmaceuticals market owing to the wide adoption of these drugs to treat chronic diseases, such as cancer. Furthermore, the surge in R&D concerning oncology drug development is also anticipated to boost the biopharmaceuticals market for monoclonal antibodies.
- By application, the India bio-pharmaceutical is segmented into oncology, a blood disorder, metabolic disease, infectious disease, cardiovascular disease, neurological disease, immunology, and other.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on "India Biopharmaceutical Market Size, Share, By Type (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and, Others) and By Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others) - Trends, Analysis, and Forecasts till 2034"
The prominent player operating in the India Biopharmaceutical market includes Bar Code India Limited, Bartronics India Limited, Honeywell Automation India Limited, Best IT World (India) Private Limited (iBall), Intex Technologies India Limited, Pegasus Technologies Private Limited, SATO Argox India Private Limited, TVS Electronics Limited.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions Development Company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
U.S: 1 860 531 2574
RoW: 91 7775049802
Email- [email protected]
Website- www.prophecymarketinsights.com
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Custmoized Your ReportWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request for Discount



Quick contact
